Clark Capital Management Group, Inc.
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1352187
PHILADELPHIA, PA
Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,837,412
+$4,153,885 QoQ
Shares Held
214,102
+48.8% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
14 quarters on record
Voting authority
Sole 99.89817937244865.ToString("F0")%
Shared 0.ToString("F0")%
None 0.10182062755135404.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Clark Capital Management Group, Inc. holds $130,946,596 across 6 Biotechnology names. HALO ranks #4 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
1,639,968 | $78,669,264 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
90,206 | $18,009,627 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
568,676 | $14,080,417 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
214,102 | $13,837,412 | |
| 5 | EXEL |
Exelixis, Inc.
|
142,980 | $6,132,412 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487 | $217,464 |
All Filings in HALO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,837,412 | 214,102 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,683,527 | 143,886 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,885,453 | 202,965 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,227,463 | 177,383 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,129,673 | 205,762 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,549,718 | 178,827 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,851,725 | 137,172 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,389,153 | 102,925 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $1,131,798 | 29,636 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,970,048 | 34,623 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,328,702 | 33,604 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,485,704 | 33,766 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $2,220,476 | 55,222 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,354,273 | 57,873 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||